Serum Institute of India: Covishield
Vaccine Type: Non Replicating Viral Vector
Vaccine Trial & Approval Tracker
This vaccine is approved.
Phase 1: 0 Trials
There are no trials for this phase.
Phase 2: 1 Trial
-
CTRI/2020/08/027170
India
Phase 3: 1 Trial
-
CTRI/2020/08/027170
India
Approvals
Africa Regulatory Taskforce Endorsed
Caribbean Regulatory System Emergency Use Recommendation
33 Countries
- Afghanistan
- Antigua and Barbuda
- Argentina
- Bahrain
- Bangladesh
- Barbados
- Bhutan
- Bolivia (Plurinational State of)
- Botswana
- Brazil
- Cabo Verde
- Canada
- Dominica
- Egypt
- Ghana
- Grenada
- Hungary
- India
- Jamaica
- Maldives
- Morocco
- Nepal
- Nigeria
- Saint Kitts and Nevis
- Saint Lucia
- Saint Vincent and the Grenadines
- Seychelles
- South Africa
- Sri Lanka
- Suriname
- The Bahamas
- Trinidad and Tobago
- Ukraine
This vaccine is the same formulation as the Oxford/AstraZeneca vaccine (AZD1222)
Registered Trials
-
CTRI/2020/08/027170
Phase 2/3India
Total Enrollment: 1,600
Official Trial Registration: